Start here if you're new
what it is
Enovix makes lithium-ion battery cells meant to cram more power into less space.
how it gets paid
Last year Enovix made $32M in revenue. smartphone cells was the main engine at $12.7M, or 40% of sales.
why it's growing
Full-year revenue grew about 37.9%. The latest quarter can show a much larger vs. prior year percent (e.g. ~157%) off a tiny base—do not average those into one sentence without the period label.
what just happened
Latest quarter revenue near ~$21M (heavy vs ~$8M pro-rata of ~$32M annual—possible in a ramp). EPS still about -$0.59.
At a glance
B balance sheet — gets the job done, barely
-$1.08 fy2024 eps est
$23M fy2024 rev est
deep operating losses — margin % from feeds is misleading
2.1 beta
xvary composite: 40/100 — below average
What they do
Enovix makes lithium-ion battery cells meant to cram more power into less space.
Enovix tries to win on cell architecture, or battery layout. That means more energy in the same space, so your phone or wearable lasts longer without getting bigger. The catch is scale: 570 employees and $32M of revenue means the moat is still being proven in the wild.
How they make money
$32M
annual revenue · their business grew +37.9% last year
smartphone cells
$12.7M
smart eyewear cells
$7.0M
defense cells
$6.5M
industrial and mobile cells
$5.6M
The products that matter
battery cell manufacturing
3D Silicon Lithium-ion Cells
$31.8M reported revenue base
this is the commercial story. management is targeting energy density above 900 Wh/L, but right now you still have a $31.8M revenue business proving it can manufacture, not a scaled platform.
core revenue driver
battery safety technology
BrakeFlow™ & encapsulation
differentiation claim
the safety pitch is simple: reduce thermal runaway risk while pushing for higher energy density. that matters because a better battery still fails the commercial test if customers do not trust it inside a device.
qualification lever
Key numbers
$32M
annual revenue
This is tiny next to $530M of long-term debt.
$530M
long-term debt
Debt is 16.6 times revenue. That is a lot of obligation for a small factory.
17.5%
gross margin
The product is covering its direct costs, but not the rest of the business.
n/m
operating margin
Vendor “operating margin” percent fields often mangle loss-making ramp-stage factories—use operating loss dollars from the 10-Q, not a giant positive %.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 4 — safer than 20% of stocks
- price stability 5 / 100
- long-term debt $530M (33% of capital)
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for ENVX right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue hit $21M, but the company still posted a -$0.59 EPS loss.
Latest quarter revenue vs. prior year can print huge (e.g. ~157%) while full-year growth is ~38%—different windows. Gross margin near 17.5% is the cleaner quality read; the problem is still cash burn vs ~$530M debt.
$21M
qtr revenue
-$0.59
eps (Q)
17.5%
gross margin
gross margin
17.5% gross margin matters because it is the first proof the cells can make it through the factory without getting wrecked.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the core risk is simple: Enovix still has to prove that a promising battery design can survive the ugly part of manufacturing — yield, cost, throughput, and customer qualification.
high
valuation outruns the business
ENVX trades at 32.75x sales versus a 2.35x industry average. That premium leaves very little room for a slower commercial ramp.
A stock priced on future scale gets punished fast when future scale shows up late.
high
customer qualification stays binary
the lead smartphone customer story still needs a clear launch date. Until that exists, you are underwriting a commercialization timeline the market cannot actually see.
Without a visible customer ramp, the stock stays stuck between promise and proof.
med
operating losses are still extreme
Operating losses still swamp the ~$32M revenue base—treat giant negative “margin %” fields from feeds as junk math on a ramp-stage manufacturer. Gross margin near 17.5% (reported) is the cleaner read; the business is still nowhere near self-funding.
If scale takes longer than expected, dilution or more balance sheet pressure becomes easier to imagine.
med
the technology edge stays theoretical
the company can talk about 900 Wh/L all day. If yield, cost, and throughput do not improve, the technology advantage stays in the lab instead of the income statement.
That is how a promising science project becomes a weak stock.
a ~$1B market cap on $31.8M of reported revenue means even modest delays can hit both sentiment and financing flexibility.
source: institutional data · regulatory filings · risk analysis
Pay attention to
catalyst
smartphone OEM launch date
this is the obvious one. a named launch window would move the story from speculation to revenue visibility. right now, the market is still filling in that blank itself.
unit economics
gross margin: reported vs non-GAAP
This page carries ~17.5% reported gross margin in the KPI block; some releases cite a higher non-GAAP gross margin (e.g. ~23%). Track both labels—scale without margin is just faster cash burn.
operations
manufacturing scale-up under the new leadership structure
leadership was reorganized in january 2026 to put battery manufacturing under one leader. that is a tell. management knows factory execution is the bottleneck.
next report
Q1 2026 results versus a $0.15 loss and $7.12M revenue expectation
with a 2.1 beta and a stock range of $5–$16, misses tend to get punished quickly. this is not a company with valuation air cover.
Analyst rankings
coverage read
thin
in human-speak, the current feed gives you less consensus comfort than you get with a mature stock.
what matters more
execution
for ENVX, analyst opinion matters less than customer qualification, gross margin, and manufacturing throughput.
source: institutional data
Institutional activity
institutional ownership data for ENVX is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$6
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive